A AB BS ST TR RA AC CT T O Ob bj je ec ct ti iv ve e: : This study was conducted to evaluate the efficacy of pre-emptive pregabalin compared with plasebo and diclofenac combination for attenuating postoperative pain, analgesic consumption and cognitive function after laparoscopic cholecystectomy. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : Sixty adults with ASA physical status I-III of either sex undergoing elective laparoscopic cholecystectomy were included in this prospective, randomized placebo controlled, single-blind study. Subjects were divided into two groups being 30 pat.ents in each to receive either a matching placebo or pregabalin 300 mg, administered orally 1 h before surgery. Intramuscular 75 mg diclofenac sodium was given to placebo patients 15-20 minutes before the estimated finishing time of surgery for pain relief after surgery. In the first 15 minutes after extubation, Aldrete Score and Ramsay Sedation Scale were evaluated. Mini mental test (MMT) was performed 1 hour and 6 hours after extubation. Postoperative pain was assessed by visual analogue scale (VAS). Time to first analgesic requirement, total analgesic dose and side effects were recorded. R Re es su ul lt ts s: : The difference between preoperative 1 st h and 6 th h MMT values was not statistically significant between the two groups. VAS scores were significantly higher in Group C compared to Group P (p <0.01). In Group P, the time to first analgesic rescue dose was significantly longer than in Group C (p<0.01). Total analgesic doses were significantly lower than in Group C patients (p<0.01). Sedation was significantly higher in Group P (p<0.05). C Co on nc cl lu us si io on n: : We conclude that administration of 300 mg of pregabalin 1 hour before surgery lengthens recovery time minimally, prolongs first analgesic requirement time, reduces total analgesic consumption and does not impair cognitive functions.
regabalin (S-aminomethyl-5-methylhexaninacid) was designed as a more potent successor of gabapentin. Although mechanism of action is not fully understood, pregabalin has the same binding area and a similar pharmacological profile. 1 Both gabapentin and pregabalin are alkalinized aminobutyric acid analogues developed as anticonvulsants. These drugs bind to the alpha2delta (α2δ) subunit of the presynaptic voltage-dependent calcium channel present throughout the peripheral and central nervous systems, and prevent release of nociceptive neurotransmitters such as glutamate, substance P and noradrenaline. [2] [3] [4] [5] [6] [7] Possible areas of action are peripheral, primary afferent neurons, spinal neurons and supraspinal areas. 8 It is thought that the postoperative pain has a temporary neuropathic pain component and both gabapentin and pregabalin are beneficial in reducing the central neuronal sensitization in postoperative pain. [9] [10] [11] [12] [13] Pregabalin's binding affinity to α2δ subunit is six times stronger than that of gabapentin. 14 Luo and colleagues showed that α2δ subunit up-regulation may play an important role in the process of hyper-sensitization in a study on rats with spinal nerve injuries. 15 With preemptive application of drugs, prevention of central sensitization process and achieving a better quality of analgesia post-operatively is intended. [16] [17] [18] [19] To obtain maximum clinical benefit, intraoperative complete noxious stimulus block should be achieved and this block should continue during the postoperative period. Thus, use of preemptive analgesia especially to prevent central sensitization with multimodal analgesic interventions, can reduce both acute and chronic postoperative pain. 20 After laparoscopic surgeries, pain is the most frequent complaint and the most common cause for postoperative morbidity. 21, 22 Pain associated with outpatient laparoscopic surgery may be moderate or even severe for some patients, and may require opioid treatment.
Diclofenac sodium is a phenylactic acid derivative which is formulated for oral, intramuscular and rectal use. 23 It is an effective analgesic given after operation. 24 Long-term cognitive and psychomotor impairment after anesthesia, although rare, is a serious problem. Postoperative deterioration of cognitive functions and psychomotor abilities often last short-term and are temporary. These symptoms can be observed even after very short anesthesia applications. In the period after anesthesia, memory in young patients and mental organizations in elderly are more frequently affected. 25, 26 The effect of preemptive pregabalin on early postoperative cognitive functions has not been investigated in previous studies.
In our study, we have aimed to evaluate the efficacy of a single preemptive 300 mg dose of pregabalin on postoperative recovery, pain, analgesic consumption (postoperative 24 hours) and cognitive function after laparoscopic cholecystectomy in patients undergoing total intravenous anesthesia (TIVA).
MATERIAL AND METHODS:
After the Institute's Ethics Committee approval, written informed consent was obtained from patients scheduled to undergo elective laparoscopic cholecystectomy between February 2011 and July 2011. Sixty subjects, ASA physical status I-III of both sexes were recruited for this single-blinded (research team members), prospective, randomized, controlled clinical trial.
Patients were eligible for participation if they were at least 18 years old and weighed more than 40 kg. Exclusion criteria included known allergy, sensitivity, or contraindications to pregabalin, diclofenac sodium and pethidine, or any NSAID, renal insufficiency, severe coronary, pulmonary, hepatic disease, history of previous neurological disease or seizure disorder, a history of peptic ulcer, a history of alcohol or substance abuse, ongoing therapy with sustained-release opioids, pregnancy, history of intake of non-steroidal anti-inflammatory and antidepressant drugs within 24 h before surgery and ASA IV classification status.
All the patients were examined and informed about the applicable anesthesia at the outpatient clinic one day before the surgery. During the preTurkiye Klinikleri J Med Sci 2012;32 (4) Akarsu ve ark.
Anesteziyoloji ve Reanimasyon anesthetic round, the patients were trained in the use of the visual analogue scale (VAS) pain score (0 for no pain and 10 for extremely intense pain). Mini mental test (MMT) was performed. All patients were also followed for possible side effects that may have occurred.
STUDY DESIGN
Study medications were pregabalin 300 mg capsules and placebo capsules. Patients were assigned to one of two treatment groups in single-blind randomized manner. Each new patient was assigned a consecutive study number. The study medications were administered on the day of surgery by a nurse.
1. Pregabalin group (Group P, n=30) received 300 mg pregabalin capsules (Lyrica ® capsule) 1 h before induction.
2. Placebo group (Group C, n=30) received empty capsules of similar color, taste and appearance but filled only with rice bran 1 h before the anesthetic induction.
None of the cases received any premedication. 1000 mL Ringer lactate solution was administered through the antecubital intravenous line in the operating room. Systolic, diastolic and mean blood pressures, heart rate/min and peripheral arterial SpO 2 values were recorded noninvasively with standard monitoring.
Patients were induced with remifentanil 1 µg kg −1 as IV bolus in 30-60 sec, followed by 0.25 µg kg −1 infusion. Orotracheal intubation was facilitated 2 min after IV infusion of propofol 1.5 mg kg −1 and Rocuronium 0.1 mg kg −1 . Anesthesia was maintained with propofol 100 µg kg −1 and remifentanil 0.25 µg kg -1 . The lungs were ventilated with oxygen-air (40-60%) mixture. Lung ventilation was controlled so end-tidal CO 2 value was kept between 30-35 mm Hg. Remifentanil infusion was continued at 0.25 µg kg −1 dose. Remifentanil infusion was regulated with 25-50% increase or decrease in remifentanil rate every 2-5 minutes for appropriate depth of anesthesia. In case of nondeep anesthesia, bolus remifentanil was administered with 2-5 minutes intervals at 0.5 µg kg −1 dose. For the treatment of hypotension (mean arterial pressure falls below 20% of baseline value before induction) and/or bradycardia (HR<40 beats/min) during deep anesthesia, remifentanil infusion rate was reduced by 50% and ephedrine 5 mg IV or atropine 0.5 mg IV was administered when required. Propofol infusion rate was continued unchanged.
Remifentanil and propofol infusions were reduced by 50% when skin sutures were started. Infusions were terminated after last skin suture was placed. For pain relief after surgery, a single 75 mg of dose intramuscular diclofenac sodium was given to Group C patients 15-20 minutes before the estimated ending time of surgery.
The postoperative pain intensity was measured on a VAS (VAS 0=no pain, 10=worst imaginable pain). VAS≥4 level was decided based on their need for additional analgesics. The nursing staff was allowed to provide analgesia if indicated. Pethidine 0.35 mg/kg IV was given up to 6 times per day. 
RESULTS
This study included a total of 60 patients, 24 (40%) women and 36 (60%) men, between the ages of 44-68 years. Demographic data such as age, height and weight averages were similar and no statistically significant differences were found between the groups (p>0.05) ( Table 1 ).
There was no statistically significant difference between the groups with regard to demographic data (p>0.05) (Table1).
There was no statistically significant difference between the groups with regard to extubation time (min) (p>0.05). There was a very significant statistical difference (p=0.000), between the groups with regard to time of eye opening (min) and time to respond to commands (min) ( Table 2) . When ARS were compared between the groups, there was no statistically significant difference with regard to after extubation, 5 th min, 10 th min and 15 th min values (p> 0.05) ( Table 3) .
Comparing RSS between groups, no statistically significant difference was found between the 15 th min averages after extubation (p>0.05). 30 th (33.3%) and 45 th (53.3%) min values of being fully awake and cooperative were significantly lower in Group P patients compared to Group C (p<0.01) ( Table 4 ).
Patients were evaluated by preoperative, postoperative 1 st -6 th h MMT and neurological examination. At the end of the examination, no major neurological disorders or moderate and severe levels of cognitive impairment were detected. There was no statistically significant difference between preoperative MMT values (p>0.05) ( Table 5) .
The difference between preoperative 1 st h and 6 th h MMT values of Group C and Group P was not statistically significant (p>0.05) ( Table 5 ).
The decrease in the MMT values of 1 st h regarding to preoperative value was found statistically significant in Group P (p<0.05). The increase in the value of 6 th h regarding to 1 st h value was found statistically significant (p<0. 01).
Time of first analgesic values in Group P were significantly longer than Group C (p<0.01) ( Total analgesic doses (Pethidine mg) values in Group P were significantly lower than in Group C (p<0.01) ( Table 6 ). th and 24 th h VAS values were statistically significantly lower in pregabalin groupcompared to placebo group (p<0.01) ( Table 7 ).
The overall incidence of side effects is summarized in Table 8 . The incidence of nausea was significantly less in patients receiving pregabalin compared to placebo (p<0.01). Other side effects, such as vomiting, feeling light-headed or dizzy, respiratory depression, visual disturbances, feeling of general fatigue were similar in two groups.
DISCUSSION
Rapid recovery and regaining full consciousness shortly after anesthesia are desirable features of anesthesia techniques. Quick recovery of consciousness after extubation, the adequacy of spontaneous respiration, an open airway and sufficient protective airway reflexes during early recovery minimize negative side effects of respiratory system origin. 27, 28 Preoperative alcohol consumption, drug use or premedication, sedative analgesic and anesthetic overdose may affect recovery.
Postoperative pain mechanism is complex. The purpose of preemptive drug application is to achieve a better quality of analgesia postoperatively. [16] [17] [18] [19] It is thought that the postoperative pain has a temporary neuropathic component and both gabapentin and pregabalin are beneficial in reducing the central neuronal sensitization in postoperative pain. 6 Turkiye Klinikleri J Med Sci 2012;32 (4) [29] [30] [31] NSAIDs are the most commonly prescribed analgesic medications worldwide, and their efficacy for treating acute pain has been well demonstrated. Diclofenac is a benzene-acetic acid derivative that acts, like other NSAIDs, by inhibiting cyclo-oxygenase isoforms that mediate the body's production of the prostaglandins implicated in pain and inflammation. 32 In this study, a multimodal analgesia technique was preferred and one group received preemptive pregabalin and the other received diclofenac sodium at the end of the operation, extra dose analgesic requirement was provided with low dose pethidine.
There was no statistically significant difference among the groups with regard to extubation time (min), but time to eye opening (min) and time to respond to commands (min) were longer in pregabalin group compared to the control group (p=0.000). We used ARS and RSS to evaluate recovery. There was no significant difference for ARS between the groups (p>0.05). In other studies, patients given pregabalin were found to be more sedated in the postoperative period. [33] [34] [35] In our study, similar to other studies, patients in Group P were more sedated.
Effective postoperative analgesia prevents many negative impacts of pain; for example it provides a comfortable breathing, reduces the workload of the cardiovascular system, prevents the development of thromboembolic events with early mobilization, and prevents the increase of stress response which happens via neuroendocrine and sympathetic nervous system activation.
Studies reported that pregabalin has a significant analgesic effect in acute postoperative pain. [36] [37] [38] The present study has demonstrated significant analgesic effect of the pre-emptive use of 300 mg pregabalin after laparoscopic cholecystectomy. A decrease in total analgesic consumption along with a significant decrease in VAS pain scores were found in patients who received pregabalin one hour before surgery (p<0.01). This study also demonstrated that a single postoperative dose of diclofenac sodium does not reduce the incidence of postoperative pain and analgesic consumption in patients undergoing laparoscopic cholecystectomy.
Postoperative nausea and vomiting (PONV) are common complications following anesthesia and surgery. The etiology of PONV is complex and depends on a variety of factors, including the technique of anesthesia, patient demographics, and type and site of surgery. 39 One of the most important class of drugs used to treat pain is opioids but their use is limited due to side effects such as sedation, dizziness, miosis, respiratory depression, nausea and vomiting. 40 In this study, the incidence of postoperative nausea was significantly lower with the use of pregabalin (p<0.01). This might be related to the decreased use of opioids after surgery and the consequent decrease in opioid-related adverse effects.
Pregabalin is a well-tolerated drug which has low incidence of side effects and less interaction with other drugs. Side effects such as somnolence, dizziness, confusion, headache, ataxia, and weight gain have been reported. Although most of these side effects were reported with chronic use of pregabalin, the most common side effects due postoperative use of pregabalin are dizziness, somnolence and sedation. 32, 42 In our study, side effects such as postoperative dizziness, headache and visual disturbances were seen in both groups but no statistically significant differences were found between the groups (p>0.05).
The incidence of postoperative sedation was significantly higher in the pregabalin group. 33, 34 This effect may also influence the use of opioids. It is possible that the more sedated patients in the pregabalin group would use less opioids. In our study, sedation in the postoperative period was statistically significantly higher (p<0.01) in pregabalin group compared to the control group.
The objective of postoperative cognitive function assessment is either to determine the level of recovery with determining residual effects or to investigate the mental changes caused by surgery and anesthesia. Besides the effects of agents on the respiratory and circulatory systems, the effects on memory, other cognitive functions and psychomotor capabilities are also important in determination of the duration of post-anesthetic effect. 42 Bedside cognitive function tests are very useful in determining the mental changes. These tests evaluate orientation, short-term memory, language, perception and some motor functions. Due to being short and easy to practice, MMT is a frequently applied bedside test.
MMT postoperative 1 h values were significantly lower than preoperative values in a study with inhalation agents by Chen et al. 43 Larsen et al. analyzed cognitive function and recovery in their study with propofol, desflurane and sevoflurane. 44 They reported that more rapid awakening and recovery of patients in propofol group.
In this study, we preferred propofol, an IV anesthetic agent, instead of inhalation agents; especially due to lesser effect of propofol on cognitive functions, rapid anesthesia induction and recovery, and remifentanil was used for its early starting, short-lasting anesthetic effect allowing a more rapid recovery.
The decrease in the value of 1 st h MMT regarding to preoperative value was not found statistically significant in Group C, whereas it was found statistically significant in Group P (p<0.05). However, the difference between preoperative 1 st h and 6 th h MMT values of Group C and Group P was not statistically significant (p>0.05).
CONCLUSION
We concluded that preemptive pregabalin administration does not delay postoperative recovery, reduces opioid requirements and the incidence of opioid-related side effects, decreases postoperative VAS scores and does not impair postoperative cognitive functions in patients who undergo laparoscopic cholecystectomy with TIVA.
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